T
TLC Research | Los Angeles, California
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tavapadon
Darigabat
CVL-865
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
Locations recently updated
The purpose of this trial is to measure the efficacy, safety, and tolerability of darigabat (25 milligrams \[mg\] twice daily \[BID\]) compared with...
Enrolling
Panic Disorder
Drug: Darigabat
Drug: Placebo
The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of 2 fixed doses of tavapadon and placebo in partici...
Active, not recruiting
Parkinson Disease
Drug: Tavapadon
Drug: Placebo
The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Park...
Invitation-only
Parkinson Disease
Drug: Tavapadon
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems